Detalhe da pesquisa
1.
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
Biotechnol Bioeng
; 119(10): 2784-2793, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822551
2.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
3.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336730
4.
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
Mol Ther
; 22(2): 464-475, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166483
5.
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
Mol Ther
; 22(12): 2142-2154, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25156127
6.
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Mol Ther
; 22(11): 1992-2003, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24930599
7.
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Mol Ther
; 20(12): 2355-68, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089736
8.
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
J Infect Dis
; 205(5): 772-81, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22275401
9.
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Mol Ther
; 19(12): 2269-76, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21862998
10.
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.
Nat Commun
; 12(1): 4636, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330906
11.
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Front Immunol
; 12: 694759, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335606
12.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223402
13.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495988
14.
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Nat Med
; 27(2): 279-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335322
15.
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Nat Med
; 27(2): 270-278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335323
16.
Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
Lancet
; 374(9693): 912-20, 2009 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19729196
17.
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Lancet Infect Dis
; 20(7): 816-826, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325038
18.
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.
Vaccines (Basel)
; 7(2)2019 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31096710
19.
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
N Engl J Med
; 352(25): 2598-608, 2005 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15972866
20.
Prime and target immunization protects against liver-stage malaria in mice.
Sci Transl Med
; 10(460)2018 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257955